Dose Confirmation Efficacy Study (V260-007)

NCT00092443 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1312

Enrollment

INDUSTRY

Sponsor class

Conditions

Rotavirus Infections

Interventions

BIOLOGICAL: RotaTeq™, rotavirus vaccine, live, oral, pentavalent
BIOLOGICAL: Comparator: Placebo matching RotaTeq™

Sponsor

Merck Sharp & Dohme LLC